Jefferson J W
Department of Psychiatry, Clinical Sciences Center, Madison, Wis.
J Clin Psychiatry. 1992 Oct;53(10):370-2.
Preventing and/or treating renal and other complications of long-term lithium therapy remains a challenge to clinicians. A review of studies in animals and anecdotal reports in humans suggests that potassium may have therapeutic value in this regard.
The Lithium Information Center data base of over 20,000 articles was searched under the title and subject heading of "potassium." Pertinent articles from the 303 references obtained served as the basis for this review.
Studies in rats found that dietary potassium supplementation reduced adverse effects of lithium on growth and renal function and morphology. Loss of intracellular potassium may contribute to lithium-induced electrocardiographic ST-T wave changes. Little work has been done in humans to evaluate the potential benefit of potassium supplementation.
Hypokalemia should be avoided or corrected in patients taking lithium. The role of potassium supplementation in preventing renal and other complications in the presence of normokalemia requires further investigation.
预防和/或治疗长期锂盐治疗引起的肾脏及其他并发症,对临床医生来说仍是一项挑战。对动物研究和人类轶事性报道的回顾表明,钾在这方面可能具有治疗价值。
在“钾”的标题和主题词下搜索了锂信息中心超过20000篇文章的数据库。从获得的303篇参考文献中选取相关文章作为本综述的基础。
对大鼠的研究发现,饮食中补充钾可减少锂对生长、肾功能和形态的不良影响。细胞内钾的丢失可能导致锂引起的心电图ST-T波改变。在人类中,评估补充钾的潜在益处的研究较少。
服用锂盐的患者应避免或纠正低钾血症。在血钾正常的情况下,补充钾在预防肾脏及其他并发症方面的作用需要进一步研究。